NEUROCRINE BIOSCIENCES INC (NBIX)

US64125C1099 - Common Stock

125  +1.71 (+1.39%)

After market: 125 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 165.76. This target is 32.6% above the current price.
NBIX was analyzed by 34 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 125.00115.14171.36165.76201.60 - -7.89% 37.09% 32.60% 61.28%
Up and Down Grades
Date Firm Action Rating
2024-11-11 Needham Reiterate Hold
2024-11-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 Needham Reiterate Hold
2024-10-30 Needham Reiterate Hold
2024-10-29 Needham Reiterate Hold
2024-10-17 BMO Capital Maintains Market Perform -> Market Perform
2024-10-10 Raymond James Reiterate Outperform
2024-10-08 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-10-04 RBC Capital Maintains Sector Perform -> Sector Perform
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 Barclays Maintains Overweight -> Overweight
2024-08-29 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-08-29 BMO Capital Maintains Market Perform -> Market Perform
2024-08-29 Needham Reiterate Hold
2024-08-29 RBC Capital Maintains Sector Perform -> Sector Perform
2024-08-29 Piper Sandler Upgrade Neutral -> Overweight
2024-08-29 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-19 Jefferies Maintains Buy -> Buy
2024-08-07 JP Morgan Maintains Overweight -> Overweight
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-02 Guggenheim Maintains Buy -> Buy
2024-08-02 Oppenheimer Maintains Outperform -> Outperform
2024-08-02 RBC Capital Maintains Sector Perform -> Sector Perform
2024-08-02 Barclays Maintains Overweight -> Overweight
2024-08-02 Baird Maintains Outperform -> Outperform
2024-08-02 Citigroup Maintains Neutral -> Neutral
2024-08-01 Needham Reiterate Hold
2024-07-25 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-07-25 Needham Reiterate Hold
2024-07-12 Morgan Stanley Maintains Overweight -> Overweight